| Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome O Cizmecioglu, M Arnold, R Bahtz, F Settele, L Ehret, U Haselmann-Weiß, ... Journal of Cell Biology 191 (4), 731-739, 2010 | 334 | 2010 |
| Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition O Timofeev, O Cizmecioglu, F Settele, T Kempf, I Hoffmann Journal of Biological Chemistry 285 (22), 16978-16990, 2010 | 204 | 2010 |
| PLK2 phosphorylation is critical for CPAP function in procentriole formation during the centrosome cycle J Chang, O Cizmecioglu, I Hoffmann, K Rhee The EMBO journal 29 (14), 2395-2406, 2010 | 104 | 2010 |
| Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4) O Cizmecioglu, A Krause, R Bahtz, L Ehret, N Malek, I Hoffmann Journal of cell science 125 (4), 981-992, 2012 | 92 | 2012 |
| Plk2 regulated centriole duplication is dependent on its localization to the centrosome and a functional polo-box domain O Cizmecioglu, S Warnke, M Arnold, S Duensing, I Hoffmann Cell cycle 7 (22), 3548-3555, 2008 | 79 | 2008 |
| Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1/cyclin B activity I Tumurbaatar, O Cizmecioglu, I Hoffmann, I Grummt, R Voit PloS one 6 (2), e14711, 2011 | 58 | 2011 |
| Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss O Cizmecioglu, J Ni, S Xie, JJ Zhao, TM Roberts Elife 5, e17635, 2016 | 48 | 2016 |
| Human Cdc25A phosphatase has a non-redundant function in G2 phase by activating Cyclin A-dependent kinases O Timofeev, O Cizmecioglu, E Hu, T Orlik, I Hoffmann FEBS letters 583 (4), 841-847, 2009 | 31 | 2009 |
| Polyoma small T antigen triggers cell death via mitotic catastrophe AT Pores Fernando, S Andrabi, O Cizmecioglu, C Zhu, DM Livingston, ... Oncogene 34 (19), 2483-2492, 2015 | 19 | 2015 |
| Rafting on the plasma membrane: lipid rafts in signaling and disease OA Isik, O Cizmecioglu Cell Biology and Translational Medicine, Volume 20: Organ Function …, 2023 | 13 | 2023 |
| Blocking PI3K p110β attenuates development of PTEN-deficient castration-resistant prostate cancer X Gao, Y Wang, CF Ribeiro, C Manokaran, H Chang, T Von, S Rodrigues, ... Molecular Cancer Research 20 (5), 673-685, 2022 | 11 | 2022 |
| ZAP70 activation compensates for loss of Class IA PI3K Isoforms through activation of the JAK–STAT3 pathway M Demir, O Cizmecioglu Cancer Diagnosis & Prognosis 2 (3), 391, 2022 | 8 | 2022 |
| Cholesterol biogenesis is a PTEN‐dependent actionable node for the treatment of endocrine therapy‐refractory cancers I Kaysudu, TB Gungul, S Atici, S Yilmaz, E Bayram, G Guven, ... Cancer Science 114 (11), 4365-4375, 2023 | 6 | 2023 |
| PI3K Signaling at the Crossroads of Lipid Metabolism and Cancer S Yilmaz, O Cizmecioglu | 1 | 2024 |
| Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt HB Catalak Yilmaz, M Sulaiman, OA Isik, O Cizmecioglu Turkish Journal of Biochemistry 49 (2), 210-219, 2024 | 1 | 2024 |
| p110alpha activity at the M-to-G1 transition is critical for cellular proliferation and reentry into the cell cycle O Çizmecioğlu Turkish Journal of Biology 46 (3), 207-215, 2022 | 1 | 2022 |
| Kizuna takes pole position O Cizmecioglu, I Hoffmann Nature Cell Biology 8 (10), 1050-1051, 2006 | 1 | 2006 |
| Molecular mechanisms of PI3K isoform dependence in embryonic growth S Atıcı, O Çizmecioğlu Journal of the Turkish German Gynecological Association 25 (3), 159, 2024 | | 2024 |
| The expression profiles of MCF7 cells stably-expressing wild-type and mutant TP53 and the interaction between TP53 status and CHRNA5 levels in shaping resistance to doxorubicin AM Aftab, MV Ozdeniz, B Arici, G Tok, AM Aftab, I Kaysudu, YO Carus, ... FEBS OPEN BIO 13, 91-91, 2023 | | 2023 |
| RNA related publications A Postepska-Igielska, I Grummt, W Xie, T Ling, Y Zhou, W Feng, Q Zhu, ... Cell Host Microbe 12, 71-85, 2012 | | 2012 |
Oleg TimofeevPhilipps University of MarburgVerified email at staff.uni-marburg.de
